Home » Stocks » HSDT

Helius Medical Technologies, Inc. (HSDT)

Stock Price: $16.90 USD 0.34 (2.05%)
Updated Jan 20, 2021 4:00 PM EST - Market closed
Market Cap 24.72M
Revenue (ttm) 623,000
Net Income (ttm) -16.93M
Shares Out 1.29M
EPS (ttm) -16.48
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day January 20
Last Price $16.90
Previous Close $16.56
Change ($) 0.34
Change (%) 2.05%
Day's Open 16.77
Day's Range 16.10 - 17.00
Day's Volume 38,481
52-Week Range 11.23 - 1,788.50

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation
GlobeNewsWire - 14 hours ago

NEWTOWN, Pa., Jan. 20, 2021 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, tod...

GlobeNewsWire - 1 day ago

The Company's Stock Will Continue to be Listed and Traded on The Nasdaq Stock Market

GlobeNewsWire - 5 days ago

NEWTOWN, Pa., Jan. 15, 2021 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, tod...

GlobeNewsWire - 1 week ago

Submits formal response to the U.S. Food and Drug Administration's request for additional information Submits formal response to the U.S. Food and Drug Administration's request for additional ...

GlobeNewsWire - 2 weeks ago

NEWTOWN, Pa., Jan. 05, 2021 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, is ...

GlobeNewsWire - 2 weeks ago

NEWTOWN, Pa., Jan. 04, 2021 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, tod...

GlobeNewsWire - 2 weeks ago

NEWTOWN, Pa., Dec. 31, 2020 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, ann...

Seeking Alpha - 2 months ago

Helius Medical Technologies' (HSDT) Management on Q3 2020 Results - Earnings Call Transcript

GlobeNewsWire - 2 months ago

NEWTOWN, Pa., Nov. 05, 2020 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, tod...

GlobeNewsWire - 2 months ago

New clinics increase access to PoNS Treatment in population-dense areas across Canada New clinics increase access to PoNS Treatment in population-dense areas across Canada

GlobeNewsWire - 2 months ago

NEWTOWN, Pa., Nov. 02, 2020 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (NASDAQ:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, tod...

GlobeNewsWire - 2 months ago

NEWTOWN, Pa., Oct. 26, 2020 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, ann...

GlobeNewsWire - 2 months ago

NEWTOWN, Pa., Oct. 21, 2020 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, ann...

GlobeNewsWire - 3 months ago

NEWTOWN, Pa., Oct. 19, 2020 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, tod...

GlobeNewsWire - 3 months ago

NEWTOWN, Pa., Oct. 14, 2020 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (NASDAQ: HSDT) (TSX: HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, t...

GlobeNewsWire - 3 months ago

Leading Multiple Sclerosis Experts to Inform U.S. Launch Planning and Market Access Strategies Leading Multiple Sclerosis Experts to Inform U.S. Launch Planning and Market Access Strategies

GlobeNewsWire - 4 months ago

NEWTOWN, Pa., Sept. 08, 2020 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (NASDAQ:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, ...

GlobeNewsWire - 4 months ago

NEWTOWN, Pa., Aug. 31, 2020 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, t...

GlobeNewsWire - 4 months ago

NEWTOWN, Pa., Aug. 25, 2020 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (NASDAQ:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, t...

Seeking Alpha - 5 months ago

Helius Medical Technologies, Inc. (HSDT) CEO Phil Deschamps on Q2 2020 Results - Earnings Call Transcript

Zacks Investment Research - 5 months ago

Helius Medical Technologies, Inc. (HSDT) delivered earnings and revenue surprises of 33.33% and 33.00%, respectively, for the quarter ended June 2020.

GlobeNewsWire - 5 months ago

NEWTOWN, Pa., Aug. 12, 2020 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, t...

GlobeNewsWire - 5 months ago

NEWTOWN, Pa., Aug. 10, 2020 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (NASDAQ:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, t...

Zacks Investment Research - 5 months ago

Helius Medical Technologies, Inc. (HSDT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report.

GlobeNewsWire - 5 months ago

NEWTOWN, Pa., Aug. 06, 2020 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (NASDAQ:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, t...

GlobeNewsWire - 6 months ago

NEWTOWN, Pa., July 14, 2020 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (NASDAQ:HSDT) (TSX:HSM) (“Helius” or the “Company”), announced the dismissal of a putative shareholder class...

GlobeNewsWire - 8 months ago

NEWTOWN, Pa., May 12, 2020 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (NASDAQ:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, to...

Seeking Alpha - 8 months ago

Helius Medical Technologies, Inc. (HSDT) CEO Phil Deschamps on Q1 2020 Results - Earnings Call Transcript

GlobeNewsWire - 8 months ago

122 Subject, Multicenter, Double-Blind, Randomized, Clinical Trial Finds PoNS Treatment™ Provides Significant Improvement in Balance and Gait Deficits for Individuals Who Have Experienced a Mi...

GlobeNewsWire - 8 months ago

122 Subject, Multicenter, Double-Blind, Randomized, Clinical Trial Finds PoNS Treatment™ found Significant Improvement in Balance and Gait Deficits for Individuals Who Have Experienced a Mild-...

GlobeNewsWire - 8 months ago

NEWTOWN, Pa., April 22, 2020 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (NASDAQ: HSDT) (TSX: HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness...

GlobeNewsWire - 9 months ago

NEWTOWN, Pa., March 24, 2020 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (NASDAQ:HSDT) (TSX:HSM) (“Helius” or the “Company”), today announced that its Canadian Class II license ame...

GlobeNewsWire - 10 months ago

NEWTOWN, Pa., March 18, 2020 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, ...

Seeking Alpha - 10 months ago

Helius Medical Technologies, Inc. (HSDT) CEO Phil Deschamps on Q4 2019 Results - Earnings Call Transcript

GlobeNewsWire - 10 months ago

Expands Access to PoNS Treatment™ in the Greater Toronto Area and Southwestern Ontario Expands Access to PoNS Treatment™ in the Greater Toronto Area and Southwestern Ontario

GlobeNewsWire - 10 months ago

NEWTOWN, Pa., March 02, 2020 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (NASDAQ:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, ...

GlobeNewsWire - 10 months ago

NEWTOWN, Pa., Feb. 24, 2020 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (NASDAQ:HSDT) (TSX:HSM) (“Helius” or the “Company”) CEO Philippe Deschamps has been invited to brief the US ...

GlobeNewsWire - 11 months ago

The Cline Medical Centre in Nanaimo is the Eighth Authorized  PoNS Treatment™ Clinic in Canada.

Seeking Alpha - 11 months ago

Eli Lilly's Acquisition Strategy, And Other News: The Good, Bad And Ugly Of Biopharma

Other stocks mentioned: LLY, DRRX
GlobeNewsWire - 1 year ago

NEWTOWN, Pa., Jan. 16, 2020 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) (“Helius” or the “Company”), would like to clarify that the agreement between the co...

GlobeNewsWire - 1 year ago

NEWTOWN, Pa., Jan. 16, 2020 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, a...

GlobeNewsWire - 1 year ago

Brain Mapping Foundation and Society for Brain Mapping Therapeutics name the Portable Neuromodulation Stimulator ( PoNS™) device a trailblazing technology Brain Mapping Foundation and Society ...

GlobeNewsWire - 1 year ago

NEWTOWN, Pa., Dec. 19, 2019 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) (the “Company”), a neurotech company focused on neurological wellness, announced tod...

GlobeNewsWire - 1 year ago

NEWTOWN, Pa., Nov. 22, 2019 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, a...

GlobeNewsWire - 1 year ago

NEWTOWN, Pa., Nov. 21, 2019 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, a...

GlobeNewsWire - 1 year ago

NEWTOWN, Pa., Nov. 19, 2019 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (NASDAQ:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, t...

Seeking Alpha - 1 year ago

Helius Medical Technologies, Inc. (HSDT) CEO Phil Deschamps on Q3 2019 Results - Earnings Call Transcript

Zacks Investment Research - 1 year ago

Helius Medical Technologies, Inc. (HSDT) delivered earnings and revenue surprises of 0.00% and -50.00%, respectively, for the quarter ended September 2019.

GlobeNewsWire - 1 year ago

NEWTOWN, Pa., Oct. 24, 2019 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, t...

GlobeNewsWire - 1 year ago

Demand for traumatic brain injury management brings revolutionary neurological health technologies to Canada’s capital Demand for traumatic brain injury management brings revolutionary neurolo...

About HSDT

Helius Medical Technologies, a neurotechnology company, focuses on developing, licensing, and acquiring non-invasive technologies for the treatment of symptoms caused by neurological disease or trauma. The company's product is Portable Neuromodulation Stimulator (PoNS), a medical device in Canada for the treatment of chronic balance deficit due to mild-to-moderate traumatic brain injury. Its PoNS device treats neurostimulation of cranial nerves via the tongue to restore lost function. The company is headquartered in Newtown, Pennsylvania.

Industry
Medical Devices
CEO
Philippe Deschamps
Employees
19
Stock Exchange
NASDAQ
Ticker Symbol
HSDT
Full Company Profile

Financial Performance

In 2019, HSDT's revenue was $1.50 million, an increase of 212.97% compared to the previous year's $478,000. Losses were -$9.78 million, -65.83% less than in 2018.

Financial Statements